A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors.

by Rajkumar Venkatramani, Marcio Malogolowkin, Tom B Davidson, William May, Richard Sposto, Leo Mascarenhas
Published 2013-01-01